Doctor profile · Federal record
Dr. Michelle Bowman, M.D.
Neurology Physician (CMS: Neurology) · Cincinnati, OH
- NPI 1699094532
- Accepts Medicare
- 16 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4805 Montgomery RD Ste 410
Cincinnati, OH 452122280
(513) 241-2370
fax (513) 241-6053 - Mailing address
-
4805 Montgomery RD Ste 150
Cincinnati, OH 452122280
Credentials & registration
- NPI registered
- May 2010 — 16 yrs on file
- Profile last updated
- November 3, 2025
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 2084N0400X — NUCC code
- State license (1)
- Ohio #35 123833
- Medicaid (3)
- KY #7100386690 · OH #0313747 · IN #300034124
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1699094532. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
22,327
Distinct HCPCS
10
Medicare allowed
$998,566
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1561 |
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 13,620 | 16 | $45 | |
J2350 |
Injection, ocrelizumab, 1 mg | 8,100 | 11 | $42 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 140 | 17 | $18 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 123 | 34 | $57 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 106 | 83 | $123 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 81 | 61 | $169 | |
96375 |
Injection of additional new drug or substance into vein | 38 | 18 | $13 | |
36415 |
Insertion of needle into vein for collection of blood sample | 29 | 29 | $8 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 29 | 15 | $26 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 23 | 16 | $106 |
In context: peer comparison
Among 26 peers in this city , average services per provider: 421. This provider delivers 53× the peer median.Open Payments
Industry payments received
All-time total
$1,355
Transactions
13
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| TG Therapeutics, Inc. | 3 | $951.11 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $116.75 | |
| EMD Serono, Inc. | 2 | $109.54 | |
| GENZYME CORPORATION | 3 | $82.02 | |
| Genentech, Inc. | 1 | $29.53 | |
| Medtronic, Inc. | 1 | $24.88 | |
| Novartis Pharmaceuticals Corporation | 1 | $20.96 | |
| Alexion Pharmaceuticals, Inc. | 1 | $20.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,156
Patients
199
Total drug cost
$1,245,418
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Baclofen | Generic | 241 | 64 | $10,203 |
| Gabapentin | Generic | 238 | 57 | $7,423 |
| Duloxetine Hcl | Generic | 121 | 24 | $4,518 |
| Dalfampridine Er (Dalfampridine) | Brand | 60 | 0 | $43,239 |
| Kesimpta Pen (Ofatumumab) | Brand | 60 | 0 | $564,971 |
| Prednisone | Generic | 54 | 27 | $328 |
| Bupropion Xl (Bupropion Hcl) | Brand | 53 | 0 | $909 |
| Tizanidine Hcl | Generic | 49 | 16 | $1,283 |
| Trazodone Hcl | Generic | 48 | 0 | $338 |
| Fingolimod (Fingolimod Hcl) | Brand | 43 | 0 | $24,627 |
Frequently asked questions
What is Dr. Michelle Bowman's medical specialty?
Dr. Michelle Bowman practices Neurology Physician in Cincinnati, OH.
Where does Dr. Michelle Bowman practice?
Dr. Michelle Bowman practices at 4805 Montgomery RD Ste 410, Cincinnati, OH 452122280. Office phone: 5132412370.
What is Dr. Michelle Bowman's NPI?
Dr. Michelle Bowman's National Provider Identifier (NPI) is 1699094532, issued by NPPES.
Does Dr. Michelle Bowman accept Medicare assignment?
Yes. Dr. Michelle Bowman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michelle Bowman commonly perform?
Top Medicare-reported procedures in 2023: Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg (HCPCS J1561); Injection, ocrelizumab, 1 mg (HCPCS J2350); Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS 96366). Source: CMS Medicare Physician & Other Practitioners file.